p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis*
暂无分享,去创建一个
G. Cole | S. Frautschy | F. Calon | Fusheng Yang | R. Weisbart | J. Hansen | O. Ubeda | Q. Ma | W. Beech | Qiu-lan Ma
[1] G. Frasca,et al. Integrins mediate β‐amyloid‐induced cell‐cycle activation and neuronal death , 2008 .
[2] D. Bredesen,et al. Signal transduction in Alzheimer disease: p21‐activated kinase signaling requires C‐terminal cleavage of APP at Asp664 , 2008, Journal of neurochemistry.
[3] S. Tonegawa,et al. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice , 2007, Proceedings of the National Academy of Sciences.
[4] Bernardo L Sabatini,et al. Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.
[5] W. Klein,et al. Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.
[6] R. Maccioni,et al. Aβ1-42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases , 2007, Journal of Cell Science.
[7] M. Staufenbiel,et al. Phosphorylation of Actin-Depolymerizing Factor/Cofilin by LIM-Kinase Mediates Amyloid β-Induced Degeneration: A Potential Mechanism of Neuronal Dystrophy in Alzheimer's Disease , 2006, The Journal of Neuroscience.
[8] J. Wuu,et al. Differential Expression of Synaptic Proteins in the Frontal and Temporal Cortex of Elderly Subjects With Mild Cognitive Impairment , 2006, Journal of neuropathology and experimental neurology.
[9] Mark Bowlby,et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Gallagher,et al. A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.
[11] B. Teter,et al. Antibodies against β‐amyloid reduce aβ oligomers, glycogen synthase kinase‐3β activation and τ phosphorylation in vivo and in vitro , 2006 .
[12] B. Teter,et al. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease , 2006, Nature Neuroscience.
[13] L. Mucke,et al. Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.
[14] P. T. Nguyen,et al. Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy , 2005, The Journal of Neuroscience.
[15] Takashi Morihara,et al. Dietary n‐3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease , 2005, The European journal of neuroscience.
[16] P. Greengard,et al. Regulation of NMDA receptor trafficking by amyloid-β , 2005, Nature Neuroscience.
[17] L. Van Aelst,et al. Rho GTPases, dendritic structure, and mental retardation. , 2005, Journal of neurobiology.
[18] Dominic M. Walsh,et al. Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation , 2005, The Journal of Neuroscience.
[19] Fusheng Yang,et al. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.
[20] Suzanne Paradis,et al. The Rac1-GEF Tiam1 Couples the NMDA Receptor to the Activity-Dependent Development of Dendritic Arbors and Spines , 2005, Neuron.
[21] D. Muller,et al. The Mental Retardation Protein PAK3 Contributes to Synapse Formation and Plasticity in Hippocampus , 2004, The Journal of Neuroscience.
[22] Alison R. Gregro,et al. Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1). , 2004, Journal of medicinal chemistry.
[23] C. Finch,et al. Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.
[24] Takashi Morihara,et al. Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.
[25] M. Resh,et al. Signaling from Integrins to Fyn to Rho Family GTPases Regulates Morphologic Differentiation of Oligodendrocytes , 2004, The Journal of Neuroscience.
[26] M. Ehlers,et al. Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease , 2004, Biological Psychiatry.
[27] Susumu Tonegawa,et al. Altered Cortical Synaptic Morphology and Impaired Memory Consolidation in Forebrain- Specific Dominant-Negative PAK Transgenic Mice , 2004, Neuron.
[28] O. Vitolo,et al. Dendrite and dendritic spine alterations in alzheimer models , 2004, Journal of neurocytology.
[29] C. Finch,et al. Self-assembly of Aβ1-42 into globular neurotoxins , 2003 .
[30] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[31] R. Malinow,et al. APP Processing and Synaptic Function , 2003, Neuron.
[32] R. Huganir,et al. Rapid Induction of Dendritic Spine Morphogenesis by trans-Synaptic EphrinB-EphB Receptor Activation of the Rho-GEF Kalirin , 2003, Neuron.
[33] L. Mucke,et al. Modulation of Alzheimer-Like Synaptic and Cholinergic Deficits in Transgenic Mice by Human Apolipoprotein E Depends on Isoform , Aging, and Overexpression of Amyloid β Peptides But Not on Plaque Formation , 2002, The Journal of Neuroscience.
[34] K. Mikoshiba,et al. Pak1 Is Involved in Dendrite Initiation as a Downstream Effector of Rac1 in Cortical Neurons , 2002, Molecular and Cellular Neuroscience.
[35] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[36] Ger J. A. Ramakers,et al. Rho proteins, mental retardation and the cellular basis of cognition , 2002, Trends in Neurosciences.
[37] George A. Carlson,et al. The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[38] Richard D Fetter,et al. Regulation of Postsynaptic Structure and Protein Localization by the Rho-Type Guanine Nucleotide Exchange Factor dPix , 2001, Neuron.
[39] J. Overmier,et al. Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice , 2001, Neurobiology of Aging.
[40] H. Shibasaki,et al. α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity* , 2001, The Journal of Biological Chemistry.
[41] Shoji Komai,et al. Characterization of Fyn-mediated Tyrosine Phosphorylation Sites on GluRε2 (NR2B) Subunit of theN-Methyl-d-aspartate Receptor* , 2001, The Journal of Biological Chemistry.
[42] Ann Y. Nakayama,et al. Small GTPases Rac and Rho in the Maintenance of Dendritic Spines and Branches in Hippocampal Pyramidal Neurons , 2000, The Journal of Neuroscience.
[43] L. Mucke,et al. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease , 2000, Neuroscience.
[44] H. Cline,et al. Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo , 2000, Nature Neuroscience.
[45] C. Masters,et al. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.
[46] F T Zenke,et al. Identification of a Central Phosphorylation Site in p21-activated Kinase Regulating Autoinhibition and Kinase Activity* , 1999, The Journal of Biological Chemistry.
[47] C. Holt,et al. The Neuronal Architecture of Xenopus Retinal Ganglion Cells Is Sculpted by Rho-Family GTPases In Vivo , 1999, The Journal of Neuroscience.
[48] L. Lue,et al. Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .
[49] S. Zipursky,et al. Pak Functions Downstream of Dock to Regulate Photoreceptor Axon Guidance in Drosophila , 1999, Cell.
[50] L. Tsai,et al. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity , 1998, Nature.
[51] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[52] Richard Threadgill,et al. Regulation of Dendritic Growth and Remodeling by Rho, Rac, and Cdc42 , 1997, Neuron.
[53] D. Purpura,et al. Dendritic Spine "Dysgenesis" and Mental Retardation , 1974, Science.